Ashley Jaksa is the Market Access Scientific Strategy lead at Aetion. Her role at Aetion focuses on partnering with regulatory and HTA agencies to to support their use of RWE in decision-making, and to help set methodological guidance for RWE generation. She also works with Aetion’s biopharma clients to ensure their RWE studies meet decision-makers’ evidence standards.  Previously, she has worked at CVS Health and Context Matters, Inc. She holds a bachelor’s degree from the University of Michigan-Ann Arbor and a MPH from Yale University.